The consensus molecular subtypes of colorectal cancer
2015 · Nature Medicine · 5,121 citations
https://doi.org/10.1038/nm.3967
S
Scott Kopetz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.9K
Papers
57.6K
Citations
109
h-index
472
i10-index
Scott Kopetz is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer & Cancer Genomics and Diagnostics. The author has an h-index of 109, co-authored 1644 publications.
ORCID: 0000-0001-9647-3416Papers by this author
worksDurable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
2018 · Journal of Clinical Oncology · 2,004 citations
https://doi.org/10.1200/jco.2017.76.9901
<i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
2013 · Genome Research · 609 citations
https://doi.org/10.1101/gr.152942.112
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated <i>BRAF</i> V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
2021 · Journal of Clinical Oncology · 503 citations
https://doi.org/10.1200/jco.20.02088
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
2020 · Nature Reviews Clinical Oncology · 359 citations
https://doi.org/10.1038/s41571-020-0392-0
Biomarker-guided therapy for colorectal cancer: strength in complexity
2019 · Nature Reviews Clinical Oncology · 317 citations
https://doi.org/10.1038/s41571-019-0241-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat